Literature DB >> 6886421

Degradation of the heparin matrix of mast cell granules by cultured fibroblasts.

F M Atkins, D D Metcalfe.   

Abstract

The ability of cultured rat fibroblasts to phagocytose rat peritoneal mast cell granules has been previously demonstrated by light and electron microscopy. To determine if the heparin matrix of ingested granules could be degraded by fibroblasts after phagocytosis, the heparin within peritoneal mast cells was labeled with [35S]sulfate in vivo. The 35S-labeled rat peritoneal mast cells were purified and their granules were isolated and shown to contain [35S]heparin proteoglycan. Incubation of [35S]heparin proteoglycan-containing granules with cultured rat fibroblasts revealed internalization of radioactivity by the fibroblasts over the first 24 hr consistent with phagocytosis of the granules by these fibroblasts. The [35S]heparin proteoglycan internalized by the fibroblasts was shown to decrease in size over 72 hr indicating that the fibroblasts were capable of degrading the heparin within the ingested granules. Degradation of [35S]heparin proteoglycan within the fibroblast was accompanied by the appearance of free [35S]sulfate in the extracellular compartment. Similar findings were obtained using cultured human fibroblasts. These data demonstrate for the first time that both rat and human fibroblasts are not only capable of ingesting mast cell granules but also of degrading mast cell granule heparin proteoglycan. This ingestion and degradation of mast cell granules by fibroblasts may represent an important mechanism in the regulation of the biologic expression of heparin and other granule-associated mediators in immediate hypersensitivity reactions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6886421

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Central nervous system neurons acquire mast cell products via transgranulation.

Authors:  M Wilhelm; R Silver; A J Silverman
Journal:  Eur J Neurosci       Date:  2005-11       Impact factor: 3.386

Review 2.  Regulation and function of mast cell proteases in inflammation.

Authors:  C Huang; A Sali; R L Stevens
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

Review 3.  Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing.

Authors:  Jeffrey Douaiher; Julien Succar; Luca Lancerotto; Michael F Gurish; Dennis P Orgill; Matthew J Hamilton; Steven A Krilis; Richard L Stevens
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

Review 4.  Immunoregulatory abnormalities in atopic dermatitis.

Authors:  D Y Leung; R S Geha
Journal:  Clin Rev Allergy       Date:  1986-02

Review 5.  Mast cells, fibroblasts, and fibrosis. New clues to the riddle of mast cells.

Authors:  K L Choi; H N Claman
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

6.  Responses of dermal mast cells to injury.

Authors:  S O el Sayed; M Dyson
Journal:  J Anat       Date:  1993-06       Impact factor: 2.610

7.  Oxidative degradation of rat mast-cell heparin proteoglycan.

Authors:  D D Metcalfe; H L Thompson; S J Klebanoff; W R Henderson
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

8.  Mast cell restricted mouse and human tryptase·heparin complexes hinder thrombin-induced coagulation of plasma and the generation of fibrin by proteolytically destroying fibrinogen.

Authors:  Alicia Prieto-García; Dominick Zheng; Roberto Adachi; Wei Xing; William S Lane; Kyungmee Chung; Paul Anderson; Philip M Hansbro; Mariana Castells; Richard L Stevens
Journal:  J Biol Chem       Date:  2012-01-10       Impact factor: 5.157

9.  Stimulation of mast cells leads to cholesterol accumulation in macrophages in vitro by a mast cell granule-mediated uptake of low density lipoprotein.

Authors:  J O Kokkonen; P T Kovanen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

10.  Mast cells and tumors. The specific enhancement of tumor proliferation in vitro.

Authors:  W R Roche
Journal:  Am J Pathol       Date:  1985-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.